ASCO: Olaparib May Have Promise in Breast Cancer

posted on Jun 08 by MedPage Today OB/Gyn in the Uncategorized category CHICAGO (MedPage Today) -- Treatment with the investigational poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor olaparib may have some activity against triple-negative breast cancer when combined with paclitaxel, researchers suggested here.